 |
인쇄하기
취소
|
Dong-A to develop molecular diagnostic technology
Published: 2011-07-28 06:56:00
Updated: 2011-07-28 06:56:00
Dong-A Pharmaceutical and the US-based Nanogea announced on July 22 that both companies have signed a letter of intent for the co-development and commercialization of new molecular diagnostics, using the latter’s proprietary NanoCone-Enabled Atomic Microscopy technology to detect Prostate Specific Antigen at the single molecular level.
Nanogea is a nano-bioscience company focused on commerci...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.